Skip to main content
. 2021 Feb 25;8:585691. doi: 10.3389/fcvm.2021.585691

Figure 5.

Figure 5

Validation of the interaction between EZH2 and Snora33. (A) Predicted interaction strength between EZH2 and Snora33 using catRAPID. Among a thousand of random RNA sequences, Snora33 ranked 97% propensity to interact with EZH2. (B) RNA pull-down analysis to confirm the direct interaction between Snora33 and EZH2. Biotin was conjugated to the 3′ of Snora33 RNA in vitro, followed by streptavidin pull-down assay. Immunoblotting was performed with anti-EZH2 antibody using the elute, flow-through and input samples.